Profile
Dr. David Fuller is a Chief Medical Officer at Dimerix Ltd. and a Chairman at EpiAxis Therapeutics Pty Ltd. He is on the Board of Directors at Resonance Health Ltd. Dr. Fuller was previously employed as a Chief Medical Officer by Race Oncology Ltd., a Non-Executive Director by AdAlta Ltd., an Independent Non-Executive Director by Dimerix Bioscience Pty Ltd., and a Non-Executive Director by Linear Clinical Research Ltd. He received his undergraduate degree from The University of Sydney.
David Fuller active positions
| Companies | Position | Start |
|---|---|---|
| DIMERIX LIMITED | Chief Tech/Sci/R&D Officer | 2023-09-30 |
| RESONANCE HEALTH LIMITED | Director/Board Member | 2026-04-27 |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Chairman | 2020-06-30 |
Former positions of David Fuller
| Companies | Position | End |
|---|---|---|
| ADALTA LIMITED | Director/Board Member | 2026-04-16 |
| RACURA ONCOLOGY LTD | Chief Tech/Sci/R&D Officer | 2022-11-10 |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Director/Board Member | - |
Linear Clinical Research Ltd. | Director/Board Member | - |
Education of David Fuller
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Resonance Health Ltd.
Resonance Health Ltd. Medical/Nursing ServicesHealth Services Operates as a healthcare company, which involves in the development and commercialization of technologies & services for radiological images | Health Services |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dimerix Ltd.
Dimerix Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of biopharmaceutical drugs | Health Technology |
AdAlta Ltd.
AdAlta Ltd. BiotechnologyHealth Technology Discovers and develops i-body drugs to treat fibrotic diseases | Health Technology |
Linear Clinical Research Ltd. | |
Dimerix Bioscience Pty Ltd.
Dimerix Bioscience Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops therapy for chronic kidney disease | Health Technology |
Race Oncology Ltd.
Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology Develops clinical drugs for breast cancer | Health Technology |
- Stock Market
- Insiders
- David Fuller
















